Sprint Bioscience Balance Sheet Health
Financial Health criteria checks 6/6
Sprint Bioscience has a total shareholder equity of SEK18.7M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK48.3M and SEK29.6M respectively. Sprint Bioscience's EBIT is SEK14.3M making its interest coverage ratio -12.1. It has cash and short-term investments of SEK36.0M.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | -12.1x |
| Cash | SEK 36.01m |
| Equity | SEK 18.69m |
| Total liabilities | SEK 29.61m |
| Total assets | SEK 48.30m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: SPRINT's short term assets (SEK43.7M) exceed its short term liabilities (SEK29.6M).
Long Term Liabilities: SPRINT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: SPRINT is debt free.
Reducing Debt: SPRINT had no debt 5 years ago.
Debt Coverage: SPRINT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SPRINT has no debt, therefore coverage of interest payments is not a concern.